Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIVTAT

Details for Australian Patent Application No. 2007340162 (hide)

Owner Revance Therapeutics, Inc.

Inventors Waugh, Jacob M.; Lee, Jae Hoon

Agent Freehills

Pub. Number AU-A-2007340162

PCT Pub. Number WO2008/082889

Priority 60/882,632 29.12.06 US

Filing date 12 December 2007

Wipo publication date 10 July 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/082889 Priority application(s): WO2008/082889

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007340172-Process for regenerating catalyst for a hydrocarbon conversion zone

2007340158-Transport molecules using reverse sequence HIV-TAT polypeptides